VGViviane Gnemmi

Viviane Gnemmi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Viviane Gnemmi has a total of 587 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Implication de la mucine membranaire MUC1 dans la plasticité épithéliale rénale

    by Viviane Gnemmi

    MUC1 est une mucine membranaire dont l'expression est augmentée et altérée dans le cancer et l'ischémie rénale. La transition épithélium-mésenchyme (TEM) est un processus dynamique de plasticité cellulaire impliqué dans la progression métastatique et la réparation tissulaire. Nos travaux montraient l'implication de MUC1 dans la plasticité épithéliale rénale à travers l'action de MUC1 dans des lignées cancéreuses rénales et dans des modèles murin et humain de régénération rénale. Dans le carcinome rénal, nous démontrions que (i) MUC1 et SNAIL, facteur de transcription de la TEM, étaient surexprimés dans une série de carcinomes sarcomatoïdes, (ii) SNAIL augmentait indirectement l'expression MUC1, (iii) la surexpression de MUC1 induisait la TEM, (iv) le domaine C-terminal de MUC1 (MUC1-C) augmentait l'interaction de la beta-caténine avec le promoteur de SNAIL favorisant l'activité transcriptionnelle de SNAIL, et (v) le blocage de la localisation nucléaire de MUC1-C diminuait l'activation de la voie Wnt /beta caténine et celle de SNAIL. Au total, nos résultats démontraient que MUC1 est un acteur de la TEM rénale associé au cancer et apparaît comme une nouvelle cible thérapeutique.Dans la régénération rénale, nous montrions que (i) la régénération rénale s'accompagnait d'une plasticité épithéliale transitoire compatible avec une TEM dans un modèle murin et sur des biopsies de greffon humain, (ii) MUC1 était induite au cours de la TEM associée à la régénération, (iii) l'absence de MUC1 (souris Ko Muc1)s'associait à des lésions tubulaires rénales plus sévères, et (iv) l'induction de MUC1 était inversement corrélée au degré de fibrose rénale. Au total, nos résultats suggèrent un rôle de néphroprotection conféré par MUC1 aux cellules épithéliales rénales au cours de la régénération.

  • Evolving landscape of thrombotic microangiopathy in kidney transplant recipients in the post–C5 inhibitor era

    by Léo Drapeau, Jean Paraire, Mehdi Maanaoui, Viviane Gnemmi, François Provôt, Rémi Lenain, Christophe Masset, Christine Kandel-Aznar, Clarisse Kerleau, Karine Autain-Renaudin, et al.


  • Open Access

    Alcohol-related hepatitis induces a specific fibrosis profile through YAP activation in myofibroblasts

    by Line Carolle Ntandja Wandji, Mohamed Bou Saleh, Cyril Sobolewski, Mehdi El Amrani, Fabrice Bray, Emmanuel Boleslawski, Jérôme Eeckhoute, Pierre-Jean Devaux, François Maggiotto, Solenne Taront, et al.


  • Identification of Renal Transcripts Associated with Kidney Function and Prognosis in ANCA-Associated Vasculitis

    by Benoît Brilland, Jérémie Riou, Thomas Quéméneur, Cyrille Vandenbussche, Nathalie Merillon, Andrea Boizard-Moracchini, Maëva Roy, Maïa Despré, Giorgina Barbara Piccoli, Assia Djema, et al.

    Key Points: Large-scale kidney transcriptomics identifies a 12-gene signature, including CLU and C3 , predicting kidney failure in ANCA-associated vasculitis. This molecular signature outperformed Berden, renal risk score, and ANCA kidney risk score clinicopathologic classifications. ANCA-associated vasculitis with GN kidneys show broad immune dysregulation, notably in complement, TGF β , and immunometabolism pathways. Background: ANCA-associated vasculitis with GN (AAV-GN) frequently progresses to kidney failure. However, tools for risk stratification of kidney outcomes remain limited. Existing approaches inadequately capture the molecular complexity underlying kidney injury, despite its potential value to tailor therapeutic management. We explored whether kidney transcriptomics could identify molecular signatures linked to kidney outcomes. Methods: We included 199 patients with AAV-GN from two multicenter biobanks, and 23 controls. Kidney biopsies were profiled using NanoString nCounter to assess the expression of 750 immune-related genes. We conducted differential gene expression analysis, pathway enrichment analysis, and immune cell infiltration estimation to explore associations with kidney function and survival. A 12-gene prognostic signature was developed through least absolute shrinkage and selection operator–penalized Cox regression and compared with established histologic classifications (Berden classification, renal risk score, and ANCA kidney risk score) with robust internal validation. Results: AAV-GN demonstrated extensive immune dysregulation with 150 differentially expressed genes versus controls, highlighting complement activation, immune cell recruitment and activation, TGF β signaling, and immunometabolism pathways. Immune cell infiltration was marked by increased macrophages, dendritic cells, neutrophils, and T-cell subsets, reflecting broad immune activation. Initial eGFR correlated with the expression of 319 genes. A 12-gene signature ( CLU , C3 , LTF , FLT1 , PLCG2 , FES , PRKCD , TXNIP , SLC7A5 , PTEN , NRBF2 , and NFATC1 ) was significantly more strongly associated with kidney survival than were established histologic classifications (adjusted P value < 0.0001). Both high expression and low expression of several immune pathways (especially lymphocyte trafficking) were associated with better outcomes compared with intermediate expression. Conclusions: Transcriptomic analysis of kidney biopsies in AAV-GN identified 150 differentially expressed immune-related genes and led to the development of a 12-gene signature that correlated strongly with kidney survival, outperforming established histologic classifications.


  • Open Access

    Molecular diagnosis of kidney allograft rejection based on the Banff Human Organ Transplant gene panel: A multicenter international study

    by Dina Zielinski, Valentin Goutaudier, Marta Sablik, Gillian Divard, Olivier Aubert, Alexis Piedrafita, Fariza Mezine, Jessy Dagobert, Anais Certain, Blaise Robin, et al.


  • Histologic Features Associated with Kidney Survival in Scleroderma Renal Crisis

    by Yannick Binois, David Buob, Marie-Sophie Meuleman, Idris Boudhabhay, Pierre Isnard, Marion Rabant, Viviane Gnemmi, Laurent Daniel, Isabelle Brocheriou, Clement Gosset, et al.

    Key Points: Kidney pathology in scleroderma renal crisis was heterogeneous, with three histologic patterns of kidney injury identified by hierarchical cluster analysis. Creatinine, acute arteriolar thrombotic microangiopathy, and onion skinning in small arteries were associated with a higher risk of kidney failure. Complement system was activated in these injured vessels. Background: Scleroderma renal crisis (SRC) is a severe complication of systemic sclerosis that is associated with higher morbidity and mortality. However, limited data are currently available regarding the factors affecting kidney outcome during SRC. The objective of this study was to describe kidney histopathology in SRC and to evaluate its association with kidney failure. Methods: We performed a French multicenter retrospective study that included 65 patients who underwent a kidney biopsy in the context of SRC between 2006 and 2020. Nonsupervised hierarchical cluster analysis was used to identify histologic patterns. Cox model was performed to estimate the hazard ratios associated with histologic parameters for kidney failure, defined as the need for long-term dialysis therapy or eGFR 2 at the last follow-up. Multiplexed sequential immunofluorescence and proximity ligation assay was used in kidney biopsies to analyze complement system activation. Results: Kidney pathology in SRC was more heterogeneous than expected, with three histologic patterns of kidney injury identified by cluster analysis. Multivariable analysis showed that together with creatinine at presentation, acute arteriolar thrombotic microangiopathy and onion skinning in small arteries were independently associated with the risk of kidney failure. Multiplex immunofluorescence identified fractions from the complement classical pathway in arterioles and arteries in SRC, while proximity ligation experiments confirmed the in situ activation of classical pathway C3 convertase. Complement terminal pathway fraction C5b-9 was localized in injured arteries. Conclusions: This study shows that the clinical definition of SRC encompasses heterogeneity in the patterns of kidney injury. Acute arteriolar thrombotic microangiopathy and onion skinning were associated with kidney failure. Complement system was activated in these injured vessels.


  • Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy

    by Marie-Sophie Meuleman, Florent Petitprez, Matthew C. Pickering, Moglie Le Quintrec, Mikel Rezola Artero, Anna Duval, Marion Rabant, Alyssa Gilmore, Olivia Boyer, Julien Hogan, et al.

    Key Points: We evidenced terminal pathway activation (C5b-9 deposits) in most of the glomeruli on kidney biopsy of C3 glomerulopathy. The amount of C5b-9 deposits correlated with disease prognosis in C3 glomerulopathy. Increased terminal pathway activation was found predominantly in a subgroup exhibiting an immuno-fibroblastic signature. Background: C3 glomerulopathy is a rare disease resulting from an overactivation of the complement alternative pathway. Although there is also evidence of terminal pathway activation, its occurrence and consequences on the disease have been poorly studied. Methods: We retrospectively studied a cohort of 42 patients diagnosed with C3 glomerulopathy. We performed centralized extensive characterization of histological parameters. Kidney C5b-9 staining was performed as a marker of terminal pathway activation; intrarenal immune response was characterized through transcriptomic analysis. Results: Eighty-eight percent of biopsies showed C5b-9 deposits in glomeruli. Biopsies were grouped according to the amount of C5b-9 deposits (no or low n=15/42, 36%; intermediate n=15/42, 36%; and high n=12/42, 28%). Patients with high C5b-9 deposits significantly differed from the two other groups of patients and were characterized by a significant higher histological chronicity score (P = 0.005) and lower outcome-free survival (P = 0.001). In multivariable analysis, higher glomerular C5b-9 remained associated with poor kidney prognosis after adjustment. One third of the 847 studied immune genes were upregulated in C3 glomerulopathy biopsies compared with controls. Unsupervised clustering on differentially expressed genes identified a group of kidney biopsies enriched in high glomerular C5b-9 with high immune and fibroblastic signature and showed high chronicity scores on histological examination. Conclusions: In a cohort of patients with C3 glomerulopathy, intrarenal terminal pathway activation was associated with specific histological phenotype and disease prognosis.


  • Open Access

    Time-of-day-dependent variation of the hepatic transcriptome and metabolome is disrupted in non-alcoholic fatty liver disease patients

    by Manuel Johanns, Joel T. Haas, Violetta Raverdy, Jimmy Vandel, Julie Chevalier-Dubois, Loic Guille, Bruno Derudas, Benjamin Legendre, Robert Caiazzo, Helene Verkindt, et al.

    Liver homeostasis is ensured in part by time-of-day-dependent processes, many of them being paced by the molecular circadian clock. Liver functions are compromised in non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), and clock disruption increases susceptibility to non-alcoholic fatty liver disease (NAFLD) progression in rodent models. We therefore investigated whether time-of-day-dependent transcriptome and metabolome are significantly altered in human NAFL and NASH livers. Liver biopsies, collected within an 8 hour- window from a carefully phenotyped cohort of 290 patients and histologically diagnosed to be either normal, NAFL or NASH hepatic tissues, were analyzed by RNA sequencing and unbiased metabolomic approaches. Time-of-day-dependent gene expression patterns and metabolomes were identified and compared between histologically normal, NAFL and NASH livers. We provide here a first-of-its-kind report of a daytime-resolved human liver transcriptome-metabolome and associated alterations in NAFLD. Transcriptomic analysis showed a robustness of core molecular clock components in NAFL and NASH livers. It also revealed stage-specific, time-of-day- dependent alterations of hundreds of transcripts involved in cell-to-cell communication, intra- cellular signaling and metabolism. Similarly, rhythmic amino acid and lipid metabolomes were affected in pathological livers. Both TNFa and PPARγ signaling are predicted as important contributors to altered rhythmicity. NAFLD progression to NASH perturbs time-of-day-dependent processes in human livers, while core molecular clock component differential expression is maintained.

  • Open Access

    Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects

    by Edmone Dewaeles, KévIn Carvalho, Sandy Fellah, Jaewon Sim, Nihad Boukrout, Raphaelle Caillierez, Hariharan Ramakrishnan, Cynthia Van der Hauwaert, Jhenkruthi Vijaya Shankara, Nathalie Martin, et al.

    Cisplatin is a potent chemotherapeutic drug that is widely used in the treatment of various solid cancers. However, its clinical effectiveness is strongly limited by frequent severe adverse effects, in particular nephrotoxicity and chemotherapy-induced peripheral neuropathy. Thus, there is an urgent medical need to identify novel strategies that limit cisplatin-induced toxicity. In the present study, we show that the FDA-approved adenosine A2A receptor antagonist istradefylline (KW6002) protected from cisplatin-induced nephrotoxicity and neuropathic pain in mice with or without tumors. Moreover, we also demonstrate that the antitumoral properties of cisplatin were not altered by istradefylline in tumor-bearing mice and could even be potentiated. Altogether, our results support the use of istradefylline as a valuable preventive approach for the clinical management of patients undergoing cisplatin treatment.


  • Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma

    by Julien Calderaro, Luca Di Tommaso, Pascale Maillé, Aurélie Beaufrère, Cong Trung Nguyen, Lara Heij, Viviane Gnemmi, Rondell P. Graham, Frédéric Charlotte, Suzanne Chartier, et al.